Wendy Y. Craig, PhD

Wendy Y. Craig, PhD2017-10-06T15:33:41+00:00

Wendy Y. Craig, PhD

Research Navigator

Research Interests

  • Risk factor identification and evaluation
  • Assay development and implementation
  • Clinical screening

Background & Experience

Wendy Y. Craig, Ph.D. is a Research Navigator at Maine Medical Center (MMC). Dr. Craig received a B.Sc. in biochemistry from the University of Bath, UK (1981), a Ph.D. in physiology from Stanford University (1986) and has a background that spans basic, clinical laboratory, and clinical research.

During her research career, Dr. Craig has acquired extensive experience in study development, design, implementation, analysis, and publication. She has also developed experience in and a passion for education. As Research Navigator, Dr. Craig is responsible for supporting and mentoring investigators at all stages in the research pathway. Her goal is to reduce the logistic barriers to research in all departments at MMC, with a focus on implementing a systematic program to guide new investigators through the intellectual, practical and regulatory processes that must occur before data collection begins.

Selected Publications

Crovo D, Richard JM, Craig WY, Curry CS, Pisini J. Does Pain Reduction with Oral Steroids Predict Pain Reduction after a First-Time Cervical Epidural Steroid Injection in Patients with Cervical Radicular Pain?–A Pilot Study. Pain Medicine, 2017 Mar 3. Doi: 10.1093/pm/pnx008.

Daniel I. Spratt MD, India Stewart BS, Clara Savage MD MPH, Wendy Craig PhD, Norman P. Spack MD, Donald Walt Chandler PhD, Lindsey V. Spratt BA, Toni Eimicke MS CPNP, and Jerrold S. Olshan MD. Subcutaneous Injection of Testosterone is an Effective and Preferred Alternative to Intramuscular Injection. J. Clin. Endocrinol. Metab. 2017;102(7):2349-5

Craig Curry, Jens Eldrup-Jorgensen, MD, Janelle Richard, BA, Michele C. Siciliano, MD, Wendy Y. Craig, PhD. Phenylephrine Infusion Impact on Surgical Site Infections following Lower Extremity Bypass Surgery. J. Vascular Surgery, 2017 (in press; doi: 10.1016/j.jvs.2017.05.130)

Haddow JE, Craig WY, Neveux LM, Haddow HR, Palomaki GE,Lambert-Messerlian G, Malone FD, D’Alton ME; First and Second Trimester Risk of Aneuploidy (FaSTER) Research Consortium. Implications of High Free Thyroxine(FT4) Concentrations in Euthyroid Pregnancies: The FaSTER Trial. J ClinEndocrinol Metab. 2014;99(6):2038-44.

Haddow JE, Craig WY, Palomaki GE,Neveux LM, Lambert-Messerlian G, Canick JA, Malone FD, D’Alton ME; First And Second Trimester Risk Of Aneuploidy Faster Research Consortium. Impact of adjusting for the reciprocal relationship between maternal weight and free thyroxine during early pregnancy. Thyroid. 2013;23(2):225-30.

Craig WY, Allan WC, Kloza EM, Pulkkinen AJ, Waisbren S, Spratt DI, Palomaki GE, Neveux LM, Haddow JE. Mid-gestational maternal free thyroxine concentration and offspring neurocognitive development at age two years. J Clin Endocrinol Metab. 2012;97(1):E22-8.

Craig WY, Ledue TB. The relationship between antinuclear antibody data and antibodies against extractable nuclear antigens in a large laboratory cohort. Clin Chem Lab Med. 2011;50(3):497-502.